Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines

[1]  B. Nørgård,et al.  The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease , 2017, Inflammatory bowel diseases.

[2]  S. Bühler,et al.  Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports. , 2017, Vaccine.

[3]  Steven J Brown,et al.  Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. , 2016, Gastroenterology.

[4]  M. Dubinsky,et al.  The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response , 2016, Digestive Diseases and Sciences.

[5]  F. Carrat,et al.  Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study. , 2015, Journal of Crohn's & colitis.

[6]  Nattapaun N. Thepyasuwan,et al.  Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[7]  J. Bines,et al.  Intussusception and rotavirus vaccines: consensus on benefits outweighing recognized risk. , 2014, The Pediatric infectious disease journal.

[8]  O. Nielsen,et al.  Safety of TNF-α inhibitors during IBD pregnancy: a systematic review , 2013, BMC Medicine.

[9]  D. Frasca,et al.  Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants. , 2013, Journal of Crohn's & colitis.

[10]  M. Dubinsky,et al.  Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  Sharat Singh,et al.  Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum. , 2012, Journal of immunological methods.

[12]  L. Peyrin-Biroulet,et al.  Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study* , 2011, Inflammatory bowel diseases.

[13]  S. Shariq,et al.  Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. , 2010, Journal of Crohn's & colitis.

[14]  N. Patel,et al.  Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. , 2010, The New England journal of medicine.

[15]  S. Targan,et al.  Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease , 2010, The American Journal of Gastroenterology.

[16]  Louis J. Cohen,et al.  Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  J. Stockman,et al.  Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine , 2007 .

[18]  H. Renz,et al.  Levels of Antibodies Specific to Tetanus Toxoid, Haemophilus influenzae Type b, and Pneumococcal Capsular Polysaccharide in Healthy Children and Adults , 2003, Clinical Diagnostic Laboratory Immunology.

[19]  E. Curry,et al.  Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants , 2001, The Pediatric infectious disease journal.

[20]  B. Schwartz,et al.  Intussusception among infants given an oral rotavirus vaccine. , 2001, The New England journal of medicine.

[21]  P. Heath,et al.  Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. , 1998, The Pediatric infectious disease journal.

[22]  N. Begg,et al.  Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. , 1991, BMJ.

[23]  B. Christenson,et al.  Immunity and immunization of children against tetanus in sweden. , 1991, Scandinavian journal of infectious diseases.